These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15918581)

  • 1. Highly loaded interactive mixtures for dry powder inhalers: prediction of the adhesion capacity using surface energy and solubility parameters.
    Wagner KG; Dowe U; Zadnik J
    Pharmazie; 2005 May; 60(5):339-44. PubMed ID: 15918581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactive powder mixtures].
    Zatloukal Z
    Ceska Slov Farm; 2004 Jul; 53(4):165-71. PubMed ID: 15369226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers.
    Flament MP; Leterme P; Gayot A
    Int J Pharm; 2004 May; 275(1-2):201-9. PubMed ID: 15081150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of carrier on the performance of dry powder inhalers.
    Saint-Lorant G; Leterme P; Gayot A; Flament MP
    Int J Pharm; 2007 Apr; 334(1-2):85-91. PubMed ID: 17113733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of fines on the surface energy heterogeneity of lactose for pulmonary drug delivery.
    Ho R; Muresan AS; Hebbink GA; Heng JY
    Int J Pharm; 2010 Mar; 388(1-2):88-94. PubMed ID: 20038447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
    Traini D; Young PM; Jones M; Edge S; Price R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose.
    Allahham A; Stewart PJ
    Eur J Pharm Biopharm; 2007 Nov; 67(3):732-42. PubMed ID: 17540551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E; Barrett A; Kraus D; Brody R; Harding L; Magee G
    Int J Pharm; 2009 Oct; 380(1-2):80-8. PubMed ID: 19596428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental observations of dry powder inhaler dose fluidisation.
    Tuley R; Shrimpton J; Jones MD; Price R; Palmer M; Prime D
    Int J Pharm; 2008 Jun; 358(1-2):238-47. PubMed ID: 18457930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of high shear blending on alpha-lactose monohydrate.
    Bridson RH; Robbins PT; Chen Y; Westerman D; Gillham CR; Roche TC; Seville JP
    Int J Pharm; 2007 Jul; 339(1-2):84-90. PubMed ID: 17398047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of carrier surface treatment on drug particle detachment from crystalline carriers in adhesive mixtures for inhalation.
    Dickhoff BH; de Boer AH; Lambregts D; Frijlink HW
    Int J Pharm; 2006 Dec; 327(1-2):17-25. PubMed ID: 16920287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Powder specific active dispersion for generation of pharmaceutical aerosols.
    Crowder T; Hickey A
    Int J Pharm; 2006 Dec; 327(1-2):65-72. PubMed ID: 16930884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.